 |
 |
 |
|
'Acute HCV BUT No HBV Reported' - Reports of Viral Hepatitis B and C in HIV Patients Participating in Clinical Trials of
Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF and
Cobicistat-boosted Atazanavir plus Emtricitabine/Tenofovir DF
|
|
|
Reported by Jules Levin
14th European AIDS Conference
16-19 October, 2013
Brussels, Belgium
E Quirk, H Graham, H Liu, M Rhee, D Piontkowsky, J Szwarcberg
Gilead Sciences, Foster City, CA






|
|
|
 |
 |
|
|